FREE TRACKED SHIPPING OVER $200LOT-SPECIFIC COA ON EVERY VIALSAME-DAY DISPATCH BEFORE 4 PM CTRESEARCH USE ONLY
ShopPathwaysCompareFAQBook a callContactAccountCart
KLOW 80 mg research peptide vial

Best Seller

KLOW 80 mg

For Research Purposes Only. Not for Human Consumption.

Bundle & save

Add 1 more to save 5%.

$135In stock
1
Free tracked shipping over $200$12 flat below that, tracked either way.
Overnight and 2-day optionsChoose the service at checkout.
We accept
  • Credit or debit card
  • Zelle
  • Cash App
  • Afterpay

No payment is taken on this site — instructions follow by email.

About this compound

KLOW is a multi-peptide research blend containing 50MG GHK-Cu, 10MG TB-500, 10MG BPC-157, and 10MG KPV, studied in models involving tissue-response signaling, skin biology, inflammatory pathways, connective tissue research, epithelial barrier biology, and cellular remodeling.

For laboratory research use only. Not for human or veterinary consumption, and not for use in diagnostic procedures.

Frequently researched together

Compounds commonly studied alongside this one.

Add all 3: $398

Peer-reviewed literature

Published research in which this compound appears, for research context.

  1. 01

    Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

    Reviews gene-expression data underlying GHK-Cu activity, including wound contraction, epithelialisation and antioxidant enzyme activity.

  2. 02

    The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

    Journal of Applied Physiology · 2011

    Examines tendon fibroblast outgrowth, survival under stress and migration in vitro, implicating the FAK–paxillin pathway.

  3. 03

    Thymosin Beta-4 and TB-500 in Tissue Healing, Regeneration, and Musculoskeletal Repair: A Scoping Review

    Applied Sciences · 2026

    Maps 80 studies across the TB4/TB-500 literature and notes that the evidence base is largely preclinical, with most work evaluating TB4 rather than TB-500 itself.

  4. 04

    Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease

    Inflammatory Bowel Diseases · 2008

    Evaluates KPV in DSS colitis and CD45RB-high transfer colitis models with histology and MPO endpoints.

These references describe the scientific literature in which this compound appears. They are not claims about this product, and nothing here suggests a use in humans. All products are supplied strictly for laboratory research.